Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices.

ESMO Open

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.

Published: June 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100608PMC
http://dx.doi.org/10.1016/j.esmoop.2021.100135DOI Listing

Publication Analysis

Top Keywords

recurrent ovarian
4
ovarian cancer
4
cancer era
4
era poly-adp
4
poly-adp ribose
4
ribose polymerase
4
polymerase inhibitors
4
inhibitors time
4
time re-assess
4
re-assess established
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!